本页面由Tiger Trade Technology Pte. Ltd.提供服务

Immunocore Holdings plc

29.04
-0.3500-1.19%
盘后:29.040.00000.00%19:30 EDT
成交量:21.97万
成交额:641.37万
市值:14.96亿
市盈率:-81.44
高:29.73
开:29.48
低:29.02
收:29.39
52周最高:40.71
52周最低:27.56
股本:5,149.86万
流通股本:4,583.49万
量比:0.50
换手率:0.48%
股息:- -
股息率:- -
每股收益(TTM):-0.3566
每股收益(LYR):-0.7054
净资产收益率:-4.47%
总资产收益率:-0.16%
市净率:3.56
市盈率(LYR):-41.17

数据加载中...

2023/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/08

关联方拟减持公告

144 - Report of proposed sale of securities
2023/04/19

关联方拟减持公告

144 - Report of proposed sale of securities
2023/04/17

关联方拟减持公告

144 - Report of proposed sale of securities
2023/04/17

关联方拟减持公告

144 - Report of proposed sale of securities
2023/04/06

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/01

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/01/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/20

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals